We are live on ! Find out more
ATRC icon

AtriCure

160 hedge funds and large institutions have $924M invested in AtriCure in 2019 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 67 increasing their positions, 40 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,068% more call options, than puts

Call options by funds: $887K | Put options by funds: $28K

93% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 14

68% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 40

9% more funds holding

Funds holding: 147160 (+13)

0.14% less ownership

Funds ownership: 89.45%89.31% (-0.14%)

12% less capital invested

Capital invested by funds: $1.05B → $924M (-$130M)

50% less funds holding in top 10

Funds holding in top 10: 63 (-3)

Holders
160
Holders Change
+13
Holders Change %
+8.84%
% of All Funds
3.46%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
27
Increased
67
Reduced
40
Closed
14
Calls
$887K
Puts
$28K
Net Calls
+$859K
Net Calls Change
-$6.43M
Name Holding Trade Value Shares
Change
Change in
Stake
PCMI
76
Paradigm Capital Management Inc
New York
$1.08M
PCM
77
Pentwater Capital Management
Florida
$1.07M +$456K +15,000 +60%
GAM
78
Grandview Asset Management
Pennsylvania
$996K -$12.1K -400 -1%
New York State Common Retirement Fund
79
New York State Common Retirement Fund
New York
$991K +$125K +4,100 +12%
Federated Hermes
80
Federated Hermes
Pennsylvania
$834K -$5.01M -164,818 -84%
WCM Investment Management
81
WCM Investment Management
California
$795K +$901K +29,678 New
EGM
82
Engineers Gate Manager
New York
$790K -$38.6K -1,270 -4%
UBS AM
83
UBS AM
Illinois
$723K -$1.4K -46 -0.2%
CS
84
Credit Suisse
Switzerland
$656K -$116K -3,803 -13%
AIG
85
American International Group
New York
$630K -$23.1K -762 -3%
Stifel Financial
86
Stifel Financial
Missouri
$623K -$131K -4,327 -16%
PP
87
PDT Partners
New York
$617K -$106K -3,486 -13%
UCFA
88
United Capital Financial Advisors
Texas
$536K -$61 -2 -0%
Morgan Stanley
89
Morgan Stanley
New York
$519K -$1.82M -59,895 -76%
State Board of Administration of Florida Retirement System
90
State Board of Administration of Florida Retirement System
Florida
$467K
AQR Capital Management
91
AQR Capital Management
Connecticut
$459K +$68.4K +2,252 +15%
VRS
92
Virginia Retirement Systems
Virginia
$458K +$57.7K +1,900 +13%
Marshall Wace
93
Marshall Wace
United Kingdom
$453K +$514K +16,908 New
Sumitomo Mitsui Trust Group
94
Sumitomo Mitsui Trust Group
Japan
$439K -$218K -7,193 -31%
MIM
95
MetLife Investment Management
New Jersey
$436K
JP Morgan Chase
96
JP Morgan Chase
New York
$435K -$657K -21,633 -57%
PPA
97
Parametric Portfolio Associates
Washington
$421K -$1.06M -34,787 -69%
HI
98
HBK Investments
Texas
$421K +$33.4K +1,100 +8%
VOYA Investment Management
99
VOYA Investment Management
Georgia
$398K
AIM
100
Assured Investment Management
New York
$371K +$145K +4,777 +53%

ATRC Hedge Fund Activity: Q1 2019 in Review

160 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q1 2019, worth a combined $924M — down 12% from $1.05B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ATRC positions and 14 closed out — a net gain of 13 holders — while 67 added to existing stakes and 40 trimmed.

The largest buyer was Hood River Capital Management, adding an estimated $9.87M. The largest seller was Hudson Executive Capital, cutting an estimated $26.8M.

  • 160 institutional investors held AtriCure (ATRC) as of Q1 2019, up from 147 in Q4 2018.
  • Funds reported $924M of AtriCure stock for Q1 2019, down 12% quarter-over-quarter.
  • 27 funds opened new AtriCure positions in Q1 2019 and 14 closed out, a net change of +13 holders.
  • The largest AtriCure buyer in Q1 2019 was Hood River Capital Management, an estimated $9.87M added.
  • The largest AtriCure seller in Q1 2019 was Hudson Executive Capital, an estimated $26.8M sold.

Based on aggregated 13F filings for Q1 2019.